Qube Research & Technologies LTD Seelos Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.16 - $1.64 $0 - $3	2 New	2 $0
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $5,918 - $2.54 Million	-9,106 Reduced 10.01%	81,853 $84,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $0.93 $46,389 - $84,591	90,959 New	90,959 $62,000
Q3 2021 Nov 12, 2021	SELL	$1.69 - $2.89 $267,873 - $458,079	-158,505 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $418,453 - $1 Million	158,505 New	158,505 $418,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.